In this article we examine the current state of knowledge regarding the association of natural and synthetic fibers with fibrotic and neoplastic lung disease. It is well established that inhalation by humans of all forms of asbestos can cause pleural plaques, pleural fibrosis, interstitial fibrosis (asbestosis) of the lung parenchyma, carcinoma of the lung, and mesothelioma, but potency and risk vary with fiber type and exposure history. Numerous epidemiology studies of workers in production, fabrication, and end use (largely construction) have been published, and asbestos is probably the best studied occupational and environmental health hazard. However, important controversies persist, partly because of gaps in science and partly because of different interpretations of existing data. Currently, the most important controversies concern the risks from low-level and ambient asbestos exposure, as well as the magnitude of mesothelioma risk from chrysotile inhalation. These issues are critical not only because of their inherent scientific importance but also because of their profound implications for future asbestos use and use constraints, especially from an international perspective.
Dust control regulations in developed nations have become progressively more demanding compared with the fiber/cc exposure concentrations of the mid20th century. The current U.S. Occupational Safety and Health Administration permissible exposure limit (OSHA PEL) is 0.1 fibers/cc, time-weighted average, for all six fiber types. Although some risk assessments still predict substantial morbidity at these levels (1) , others suggest the presence of thresholds for at least asbestosis (2) . Thus, health research objectives have progressed to focus on the effects of much lower levels of asbestos fiber exposure, including ambient exposure in the vicinity of operations that use or process asbestos.
The major asbestos-exposed cohorts that continue to be studied for health effects are construction insulation workers (studied by Selikoff and colleagues), South Carolina textile workers (studied by Dement and NIOSH) and Quebec miners, millers, and factory workers (studied by McDonald and others) . The latter two chrysotile-exposed cohorts have undergone detailed exposure reconstructions. Within limits, this has facilitated attempts to examine dose-response relationships and perform risk assessments (1) . Although all these cohorts were originally reported on well before the 1990s, new information continues to appear that refines or revises that originally reported with respect to the associations between asbestos and disease. As asbestos uses have been phased out of commerce, many new fibrous materials have been used as substitutes, usually before the health hazard potential has been adequately evaluated.
In this article we discuss asbestos fibers, zeolites, man-made vitreous (mineral) fibers (MMVFs), as well as some newer nonvitreous (organic) synthetic fibers (nylon flock). We emphasize aspects of fibers and health such as fibrosis and mesothelioma not specifically addressed elsewhere in this monograph but cannot completely avoid discussion of lung cancer, which is addressed more specifically elsewhere in this monograph. Concluding remarks address current policy and research implications of fiber health hazards. The focus of discussion is on information published in the last decade of the 20th century.
Nomenclature, Sources, and Production of Fibers Asbestos Asbestos is a commercial term for six different types of naturally occurring fibrous crystals (crocidolite, amosite, chrysotile, anthophyllite, tremolite, and actinolite) composed of hydrated aluminum-magnesium silicates with varying metal composition. The two major classes are serpentine (limited to chrysotile) and amphiboles, which include all the remaining asbestos fiber types, although only chrysotile, crocidolite, and amosite have experienced widespread commercial exploitation. Chrysotile has long relatively flexible fibers, whereas amphiboles are characterized by shorter, rigid fibers. Fiber types sometimes occur in combination, e.g., chrysotile from Quebec, Canada, typically contains approximately 1% of tremolite, an amphibole. Worldwide, about 95% of asbestos produced continues to be chrysotile, and total contemporary annual production of 2.9 million tons is comparable to that of the early 1960s (3). The former Soviet Union is the leading contemporary producer, followed by Quebec, China, and Brazil.
Man-Made Vitreous Fibers
Man-made vitreous fibers, a large subset of man-made mineral fibers (MMMFs) , are synthetic, vitreous silicate fibers widely used in present-day insulation and construction industries in industrialized nations, following the dedine of widespread use of asbestos materials. MMVFs are broadly categorized into insulation wools (rock wool and slag wool), glass fibers (glass wool, continuous glass filaments and microfibers), and refractory ceramic fibers (kaolin-wool and other high-temperature insulating fibers). There are over 70 varieties of synthetic inorganic fibers (4) .
MMVFs are produced from molten rock, slag, glass, and kaolin clay as well as from combinations of silicon and aluminum oxide. Processes used in manufacture include mechanical drawing, blowing threads or droplets through jets of steam, hot air, or flame, as well as attenuation of droplets of molten liquid by centrifugation. Several additives including fire retardants, binders, wetting agents, and antifungal agents are often incorporated in the production processes (5) .
The common-purpose insulation wools, rock, glass, and slag constitute approximately 80% of MMVFs currently produced and are widely used for fire protection, acoustic and thermal insulation, acoustic ceiling tiles and panels, air-conditioning and ventilation ducts, and as growing media for horticulture. Continuous filament glass fibers comprise about 10-15% of MMVF production and are used in reinforcement of cement, plastics, resins, paper and rubber products, for textiles, and for electrical insulation. Refractory ceramic fibers (RCFs) constitute only 1-2% of MMVFs and are used in high-temperature insulation of furnaces and kilns. Other special purpose glass fibers comprise less than 1% of production and are used for high-efficiency thermal insulation in aircraft and aerospace, high-performance acoustic insulation, and as battery separation media. They constitute less than 1% of MMVFs produced and are used in aerospace, high-efficiency filtration, and other high-performance applications (4) .
Rock and slag wools were first introduced in the late 1800s. Fiberglass came into use in the 1930s and refractory ceramic fibers have been produced since the 1950s (6) . The industrial processes utilized in MMVF production facilities have changed over the years. In the early years of production, batch processes involving labor-intensive and handoperated production methods as well as poorly ventilated facilities were commonplace. In addition, dust-suppressing agents were not used. Hence, workers employed during this period had high levels of fiber dust exposure. It is also noteworthy that in the early technological phase, contaminants such as asbestos, bitumen, pitch, silica, and formaldehyde were present in many workplaces. The recent phase of MMVF production is characterized by the use of more modern production methods as well as dustsuppressing agents (mainly mineral oil) and resin binders, with significant reductions in levels of respirable fiber exposure (7) .
The annual worldwide production of (12) . Beyond shape and size, increasing attention is being paid to particle (fiber) chemistry as a determinant of variables such as dissolution behavior, ion exchange, sorption properties, and surface reactivity (13) . (2, 14) . The ROS, in particular, hydrogen peroxide, superoxide anion, and hydroxyl radical, can also be produced in cell-free systems, and thus presumably by direct chemical reactions between intrinsic metals on the fiber surface and extracellular fluids (15) . Among the most prominent mechanisms hypothesized to account for fiber carcinogenesis is DNA damage from the ROS (15, 16) .
In recent years a number of investigators have shown the susceptibility hypothesis to have some clinical relevance. For instance, it has been shown that the glutathione S-transferases (GSTs) conjugate a variety of reactive, electrophilic substrates. Deletion of the gene coding for the mu class of GSTs is associated with increased risk for mesothelioma (17) , lung cancer (18) , and asbestosis (19, 20) .
Lung Burden Studies
Fiber biopersistence is defined as the retention of fibers in the lung, over time, with regard to their number, dimensions, surface chemistry, chemical composition, surface area, and other physical characteristics (21, 22) . Long fibers are generally believed to have more biologic activity and therefore greater pathogenicity than short fibers. Experimental studies have shown that fibers that are most carcinogenic for the mesothelium have fiber lengths > 8 pm and diameters < 0.25 pm (23) . Asbestos fibers that tend to split longitudinally thereby producing thinner and longer respirable fibers are more pathogenic according to this hypothesis, whereas MMVFs (because of their brittleness) tend to split transversely resulting in shorter fibers of reduced aspect ratio (24) . Long asbestos fibers are cleared less rapidly than short fibers (25 true for all MMVFs. Although long RCFs behave in a fashion similar to asbestos fibers (26) , studies of glass wool fibers reveal that long fibers actually are cleared more rapidly than shorter fibers, perhaps because of differences between intracellular and extracellullar pH. Thus, although the ability of fibers to induce tumors in lung tissue or serosa is thought to be related to their biopersistence, there are often conflicting data and no clear thresholds (27) . These mechanistic approaches to differentiate fiber toxicity have parallels to more clinical investigations of fiber burden in exposed cohorts of asbestos and MMVF workers.
Lung burden studies involve the microscopic examination of lung tissue to identify, localize, and estimate the concentration of different fiber types in different parts of the lung. Light microscopy, electron microscopy, and more recently, energy dispersive X-ray analysis have been used. Although tremolite is present at a low concentration of approximately 1% in commercial chrysotile, lungs of workers exposed to chrysotile have a disproportionate amount of tremolite compared with chrysotile present in the pulmonary parenchyma at autopsy (28) . McDonald et al. (29) analyzed autopsy specimens from 78 Canadian mesothelioma cases and matched controls and concluded that there were significant differences in amosite, crocidolite, and tremolite but not chrysotile between the two groups. The results of subsequent studies are subject to conflicting interpretation, but most report a better association of mesothelioma risk with lung concentrations of tremolite than chrysotile (30) . Since chrysotile appears to be cleared from the parenchyma more rapidly than tremolite or other amphiboles, the concentration of tremolite may actually be a better exposure (dose) metric for chrysotile than the lung burden of chrysotile itself (31) . The paradoxical observation that a number of studies have found higher concentrations of chrysotile than amphiboles in the pleura, even when amphiboles were the predominant exposure, limits the relevance of these parenchymal measurements for delineation of risk of mesothelioma (32, 33) .
Green et al. (34) examined lung tissue from Charleston, South Carolina, chrysotile textile workers compared with a demographically matched referent group of autopsy deaths from the same hospitals and found that chrysotile levels were 5-fold higher and tremolite levels were 15-fold higher in the workers. This study estimated lifetime individual inhalation exposures. Significant positive correlations were found between lifetime cumulative exposure to asbestos and total lung burden of all asbestos fibers, as well as chrysotile and tremolite fibers individually. Pulmonary fibrosis was correlated with both cumulative exposure and the concentration of asbestos fibers in the lung, although tremolite provided a better correlation with pathologic fibrosis. The authors concluded that a component of fibrosis in these asbestos workers could be due to asbestos fibers that were subsequently cleared (i.e., chrysotile), which is consistent with current mechanistic understanding of the largely irreversible effects of inflammation in producing fibrosis. The most likely interpretation of these data is that tremolite concentrations in lung are a better metric of asbestos exposure than chrysotile concentrations but cannot necessarily be used to infer differential asbestos pathogenicity. We agree with Stayner et al. (33) that, for both technical and biologic reasons, the lung burden studies of differential fiber types do not clearly support a strong gradient in ability to cause fibrosis and mesothelioma and offer insufficient basis for discounting chrysotile as a cause of either condition.
Although previous work with asbestos indicates that long and relatively thick asbestos fibers have a tendency to become asbestos bodies, there are species-specific variations in the ability of asbestos fibers to become coated in the lung (35 (37) found ferruginous bodies in rats exposed to RCFs, Smith et al. (38) did not find ferruginous bodies in rats exposed to fiberglass or RCFs; they did, however, find some ferruginous bodies in hamsters exposed to the same MMVFs. Dufresne et al. (39) used a sheep model of pneumoconiosis to evaluate the long-term effects of glass wool, rock wool, and RCFs on lung tissue. Ferruginous bodies were not found for any of the MMVFs but were present in sheep exposed to crocidolite (the positive control group). Thus, evidence supporting MMVF ferruginous body production in animal models is limited, and it is unlikely that formation of ferruginous bodies from MMVFs could be used as a marker of exposure to MMVFs.
Human data from electron microscopic fiber burden analysis of MMVFs suggest some differences in persistence according to fiber type. Lung tissue samples from 131 workers in a cohort of glass, rock, and slag wool production workers did not show a convincing excess of any one fiber type compared to unexposed controls (40) . A study by Sebastien (41) Asbestosis (interstitial fibrosis of the lung parenchyma) typically has a slow subclinical course for many years evolving to a symptomatic phase with the typical presentation of interstitial fibrosis: dyspnea, inspiratory crackles, basilar interstitial opacities, and physiologic restriction. In the 1990s a number of studies of highly exposed workers established that radiographic manifestations of interstitial fibrosis are more common among those who smoke (42) . At the lower end of the exposure scale, non-occupational environmental exposure to asbestos in proximity to a factory has been implicated in some cases of asbestosis (43) .
Over the past 10-15 years, considerable attention has been focused on the clinical and physiologic effects of asbestos-related pleural disease (44, 45) . Substantial evidence has accumulated that pleural fibrosis is associated with measurable decrements in forced vital capacity (FVC) and diffusing capacity independent of detectable fibrosis (by high-resolution computed tomography [HRCT]) or alveolitis (by bronchoalveolar lavage) (46) .
Experience has accumulated with the use of computed tomography (CT) and HRCT for determination of asbestosis and asbestosrelated pleural disease. HRCT is generally regarded as more sensitive than chest radiographs and conventional CT, and HRCT findings correlate with restriction, as described above. Pleural disease can be more readily distinguished from normal chest wall structures, and underlying parenchyma can be imaged in the presence of extensive overlying pleura (47, 48 of dusts. Improved imaging techniques such as HRCT may improve the sensitivity of readings, particularly at the low end of the spectrum, although the reading of plain films by two experienced B readers did comparably well in one controlled study (50) . The challenge for the future is to integrate use of CT or other advances for screening and diagnosis in a cost-effective manner among the lesserexposed cohorts of the future.
Mesothelioma
Mesothelioma is a malignant disease of the lining of the chest or peritoneal cavity. The more common pleural mesothelioma classically presents with dyspnea, chest pain, and opacification of one or both lung fields; the case fatality rate is extremely high, with few documented survivors and no effective standard therapy (51) .
In the first half of the 20th century mesothelioma was an exceedingly rare (2) and reviewed in detail, with many authors finding them unpersuasive, largely from an epidemiologic perspective (33, (60) (61) (62) (63) Smith and Wright (56) also reanalyzed data from studies of gas mask workers, often cited as supporting the amphibole hypothesis (72) . Because the chrysotile-exposed gas mask workers had only a 20% excess lung cancer risk, Smith and Wright (56) concluded that they must have actually had overall low asbestos exposure and relied on excess lung cancers as a marker of substantial exposure to chrysotile. Others have used a similar argument to proportionately adjust expected mesothelioma risk to observed lung cancer excess (61) . Hence, they discount the relatively low mesothelioma rates in gas mask workers originally attributed to the lack of potency of chrysotile and ascribe it to overall low exposure.
Finally, Smith and Wright (56) added additional years of follow-up to a cohort of asbestos cement workers and found the excess of mesotheliomas to be 20% for chrysotile versus 72% for crocidolite, which gave the latter approximately a 4-fold greater potency rather than the often-cited 14-fold greater potency (73) . They ultimately conclude that chrysotile is a potent cause of mesothelioma with 25-50% of the potency of crocidolite. Because chrysotile accounts for 95-98% of global asbestos use, they argue that chrysotile causes more actual mesothelioma cases worldwide than the amphiboles.
Low-Level Exposure
Cohort studies of workers have amply documented asbestos-related disease but provide very limited dose-response information at low exposure levels of ambient environmental health concern. Of relevance, Iwatsubo et al. (74) used a large-scale, population-based sample to identify 405 hospital-based cases and controls. Through individual interviews they generated an exposure metric for each case and control on the basis of the probability of exposure, its intensity, and the frequency and duration. This revealed a dose-response relationship with an OR of 1.2 (0.8-1.8) for the low-exposure category versus 8.7 (4.1-18.5) for the high-exposure category, with the categories corresponding to estimated cumulative exposures of 0.001-0.49 fibers/mL-year; 0.50-0.99 fibers/mL-year; 1-9.9 fibers/mL-year, and >10 fibers/mL-year. (82) is frequently misinterpreted as strong support for the idea that asbestosis is necessary before there is a carcinogenic risk from asbestos exposure. The highly exposed insulation worker study from which our sample was drawn, with the requirement that all in our subsample had to have had a lung tissue sample available, makes it impossible to sustain such an unhypothesized generalization about causality. Also, there are strong arguments against the hypothesis that fibrosis is a prerequisite for carcinogenicity. This ties in with some of the concerns about the amphibole hypothesis.
Early observations finding an excess of lung cancers in asbestosis cases (83, 84) (88) .
Controversy remains about the extent to which idiopathic pulmonary fibrosis is a risk for lung cancer (89) (93) .
Animal experiments have been used in an attempt to determine whether exposure to MMVFs has health effects similar to asbestos exposure. Several studies have clearly demonstrated that MMVFs are highly carcinogenic when injected into the pleural and peritoneal cavities (11) , whereas long-term rodent inhalation studies of MMVFs have yielded conflicting findings with respect to production of lung fibrosis and cancer (27, 94) .
Inhalation studies with glass wool, glass fiber, and slag wool are generally reported negative for fibrosis. Minimal fibrosis was observed in rock wool studies at the highest exposures, but no significant excess of lung tumors was reported (95) . Ellouk and Jaurand (11) pooled data on glass wool inhalation studies and found a statistically significant increase in lung tumor development in rodents, whereas studies with slag wool, rock wool, and glass microfibers were largely negative. Although intrapleural RCF injection studies for mesothelioma were largely negative, intraperitoneal inoculation studies showed statistically significant increases in tumors for glass wool, glass microfibers, and RCFs (11) .
Inhaled RCFs induced lung tumors and mesotheliomas in both rats and hamsters, although with some inconsistencies between studies. In one study, inhalations of RCFs in rats and hamsters were negative for lung fibrosis or tumor (94) . Mesothelioma was observed in hamsters, but this did not achieve statistical significance. In a subsequent RCF study, however, the results were positive for lung fibrosis and mesotheliomas in both rats and hamsters as well as for lung cancer in rats (6) . The latter study also demonstrated a dose-response relationship for lung fibrosis. The differences in the results of the two studies have been attributed to the slightly larger diameter RCFs (4), hence reduced fiber penetration and retention, in the initial study by Smith et al. (94) .
Because continuous glass filament fibers tend to have larger diameters, typically 4-7 pm, and were negative in injection studies, they are generally thought to have minimal potential to be carcinogenic. Sufficient animal bioassays for carcinogenicity have not been conducted to completely exclude this possibility, and IARC considers these fibers unclassifiable with respect to carcinogenicity (8.11) . Clinical and Epidemiologic Studies of Nonmalignant Disease Rock and slag wool have been produced since the 1800s and glass fibers since the 1930s, with remarkably few reports of pulmonary disease due to MMVF exposure. The prevalence of nonspecific respiratory diseases (chronic obstructive pulmonary disease, emphysema, chronic bronchitis, and asthma) has been examined in a number of studies of MMVF workers. Even though there are variations in the study designs, the results have been largely negative (96, 97) . A study of ceramic fiber workers did not find any association between chronic bronchitis or wheezing and cumulative exposure to respirable fibers. However, there was a significant decrease in the forced expiratory volume and forced mid-expiratory flow related to cumulative fiber exposure in smokers (98) . This study concluded that cumulative exposure to respirable ceramic fibers may contribute to airways obstruction by promoting the effects of cigarette smoke. A recent study by Lockey et al. (99) showed a significant decrease in FVC among workers employed in RCF production jobs prior to 1980 that did not persist with analysis of subsequent production years. The reduction in RCF exposure levels after the 1980s was postulated to be responsible for eliminating any further effect of RCFs on pulmonary function. Lemasters Several studies examined chest radiographs of occupationally exposed individuals, and the results have been largely negative for evidence of pneumoconiosis (97, 98, 101, 102) . Weill et al. (103) reported radiographic findings of small irregular opacities (ILO grades 1/0 to 1/1) in 3% of glass, slag, and rock wool production workers during an initial cross-sectional survey in 1983. This study was not controlled and was subject to bias from a survivor effect. A follow-up survey of the same workers in 1993 (97) did not find any significant effect of MMVF exposure compared to local blue-collar worker controls and there was also no apparent progression of radiographic opacities in the MMVF workers.
A study of fiberglass workers (end users) by Kilburn et al. (104) reported a 13% overall prevalence of pleural abnormalities and small irregular opacities, profusion 1/0 to 2/1, due to fiberglass exposure. Possible limitations of the study were that there was insufficient information on individual historical asbestos exposure, as asbestos fibers were reportedly present in the production facility (105) , and most of the chest film readings were not blinded to exposure. Using the ILO dassification, Trethowan et al. (98) reviewed the chest films of employees of seven European plants that manufacture ceramic fibers. Small opacities profusion of 0/1 or greater were found in 13% of the radiographs. Profusion scores of 1/1 or greater were found in 18 of 592 (about 3%), 11 of whom had reported confounding exposures to other dusts. The prevalence of small opacities increased with age, smoking, and previous exposure to asbestos and importantly was not related to cumulative exposure to ceramic fibers. To date, the cumulative evidence of radiographic changes indicative of pulmonary interstitial fibrosis in MMVF workers is inconsistent.
Pleural plaques have been reported in a cohort of RCF manufacturing workers in an ongoing respiratory morbidity and mortality study in the United States. Twenty of 652 (3.1%) workers were found to have pleural changes (pleural plaques and thickening) on chest films. The prevalence was highest (12.5%) in those who began their production jobs more than 20 years ago, for an OR of 9.5. Additionally, 5 of 19 workers (26.3%) with more than 20 years total employment in RCF production jobs had pleural plaques on chest films, for an OR of 22 . A dose-response relationship with cumulative estimated exposure was also demonstrated. A nested case-control interview study showed that asbestos exposure did not account for the observed association between plaques and RCF exposure. There was no increase over historical control levels (0.5%) for small irregular opacities that would be indicative of lung fibrosis (99) . It is noteworthy that pleural abnormalities were also observed in 16 of 592 films of ceramic fiber workers (two of whom had experienced previous exposure to asbestos) in the European study by Trethowan et al. (98) . The IARC conducted a historical cohort study of mortality of approximately 25,000 MMVF workers in seven European countries (7) . This study found an increase in lung cancer mortality risk (SMR = 128) in rock/slag wool workers. The risk increased as the time since first exposure to rock/slag wool production increased. Exposures such as smoking and previous employment were considered unlikely explanations for the excess risk observed. The highest lung cancer mortality risk (SMR = 223) was observed in the early technological phase of production during which worker exposure to high levels of respirable fibers as well as arsenic (component of slag) and polycyclic aromatic hydrocarbons from furnace fumes occurred in the production facilities. Excess mortality was not observed in workers employed in the late technological phase of mineral fiber production when production changes reduced exposures. This study did not find an increased risk of mortality from nonmalignant respiratory disease or from pleural tumors. The findings in the IARC study (7) are supported by Boffetta et al. (113) , who also reported that workers employed in the early technologic phase of production, particularly rock/slag wool workers, were at higher risk of lung cancer mortality than those in other categories. More (118) . The popularity of the processes used in this plant suggests that more cases of "flock worker's lung" are likely to be identified. Additional organic fibers such as para-aramid fibrils, used in the manufacture of bulletproof vests, are being studied in animal models for toxicity. One study reported much less retention and inflammation than long chrysotile fibers (119) Although new information about cell signaling involving free radicals, growth factors, and cytokines may yet identify interventions that can abort or retard the fibrotic process, the situation is more than complemented by the molecular epidemiology approach toward differential human responses to fibers. The latter seems a more direct approach, well-rooted in clinical exposure issues, toward identification of critical pathways of disease and development of responses. This is a rapidly expanding research area throughout environmental medicine. Although in terms of fibers, research has largely been limited to asbestos, it will greatly augment our understanding of the variation in response to other mineral fibers as well. To an increasing extent, health effects are dealt with through the surrogate of risk assessment. Changing mechanistic and exposure models may alter how risk assessments for both asbestos and MMVFs should be done (122) as will the incorporation into risk assessments of susceptibility factors based on polymorphisms or other characteristics.
Epidemiologic studies have provided much insight into the pathogenicity and carcinogenicity of asbestos. Inconsistent results among studies, however, point to the omnipresent need to better characterize exposures and vulnerability. Continued tracking of the few long-term cohorts and the study of additional cohorts of people exposed to asbestos under different scenarios will play important roles in further defining the risks from asbestos. Fiber types and sizes, as well as intensity and duration of exposure to these fibers are obvious contributors to disease, yet practical exposure levels below which there is no appreciable risk have yet to be defined.
